Drug Developers Making Strides in Streamlining Patient Recruitment and Retention
According to a new study from the Tufts Center for the Study of Drug Development efforts by drug developers during the last decade to improve recruitment and retention appear to be paying off. Enrollment timelines now are equal to or shorter than planned timelines in 77% of studies, while a previous study in 2012 found that a high percentage of clinical trials had to extend planned timelines to achieve target enrollment.
For more of the report’s findings, click here.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
